In vivo CAR T-cell generation: delivery platforms, clinical progress, and translational barriers
Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of several hematological malignancies, but its broader application remains constrained by the complexity, cost, and time required for conventional ex vivo manufacturing. In vi…